Brookfield Asset Management Inc. Seagen Inc. Call Options Transaction History

Brookfield Asset Management Inc.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Sep 25, 2023	BUY	$187.64 - $206.25 $6.64 Million - $7.3 Million	35,400 Added 64.84%	90,000 $17.3 Million
Q2 2023 Aug 14, 2023	BUY	$187.64 - $206.25 $6.64 Million - $7.3 Million	35,400 Added 64.84%	90,000 $17.3 Million
Q1 2023 Sep 25, 2023	SELL	$127.59 - $203.08 $4.52 Million - $7.19 Million	-35,400 Reduced 39.33%	54,600 $11.1 Million
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $6.97 Million - $11.1 Million	54,600 New	54,600 $11.1 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.